Eukles Asset Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.76M | Sell |
19,232
-598
| -3% | -$52.3K | 0.73% | 44 |
|
|
2026
Q1 | $1.69M | Sell |
19,830
-1,622
| -8% | -$145K | 0.75% | 45 |
|
|
2025
Q4 | $1.7M | Sell |
21,452
-186
| -0.9% | -$14.6K | 0.66% | 51 |
|
|
2025
Q3 | $1.73M | Sell |
21,638
-110
| -0.5% | -$9.38K | 0.67% | 49 |
|
|
2025
Q2 | $1.98M | Sell |
21,748
-224
| -1% | -$20.4K | 0.81% | 43 |
|
|
2025
Q1 | $2.06M | Sell |
21,972
-142
| -0.6% | -$12.7K | 0.9% | 40 |
|
|
2024
Q4 | $2.01M | Sell |
22,114
-1,132
| -5% | -$108K | 0.86% | 40 |
|
|
2024
Q3 | $2.41M | Sell |
23,246
-203
| -0.9% | -$20.7K | 0.97% | 38 |
|
|
2024
Q2 | $2.28M | Buy |
23,449
+82
| +0.4% | +$7.56K | 0.98% | 39 |
|
|
2024
Q1 | $2.1M | Buy |
23,367
+993
| +4% | +$84.1K | 0.92% | 40 |
|
|
2023
Q4 | $1.78M | Sell |
22,374
-208
| -0.9% | -$15.6K | 0.84% | 41 |
|
|
2023
Q3 | $1.61M | Buy |
22,582
+258
| +1% | +$19.3K | 0.85% | 42 |
|
|
2023
Q2 | $1.72M | Buy |
22,324
+271
| +1% | +$21K | 0.88% | 42 |
|
|
2023
Q1 | $1.66M | Buy |
22,053
+32
| +0.1% | +$2.38K | 0.9% | 44 |
|
|
2022
Q4 | $1.74M | Buy |
22,021
+917
| +4% | +$68.8K | 1.01% | 37 |
|
|
2022
Q3 | $1.48M | Buy |
21,104
+1,460
| +7% | +$114K | 0.97% | 41 |
|
|
2022
Q2 | $1.57M | Buy |
19,644
+125
| +0.6% | +$9.77K | 1% | 38 |
|
|
2022
Q1 | $1.48M | Sell |
19,519
-1,508
| -7% | -$119K | 0.8% | 47 |
|
|
2021
Q4 | $1.79M | Buy |
21,027
+570
| +3% | +$44.5K | 0.87% | 46 |
|
|
2021
Q3 | $1.55M | Buy |
20,457
+1,063
| +5% | +$84.4K | 0.85% | 45 |
|
|
2021
Q2 | $1.58M | Buy |
19,394
+1,466
| +8% | +$120K | 0.87% | 43 |
|
|
2021
Q1 | $1.41M | Buy |
17,928
+309
| +2% | +$24.2K | 0.91% | 45 |
|
|
2020
Q4 | $1.51M | Buy |
17,619
+379
| +2% | +$31.3K | 1.04% | 38 |
|
|
2020
Q3 | $1.33M | Buy |
17,240
+201
| +1% | +$15.3K | 1.04% | 38 |
|
|
2020
Q2 | $1.25M | Buy |
17,039
+1,041
| +7% | +$73.9K | 1.06% | 38 |
|
|
2020
Q1 | $1.06M | Sell |
15,998
-1,389
| -8% | -$98K | 1.11% | 35 |
|
|
2019
Q4 | $1.2M | Sell |
17,387
-310
| -2% | -$21.1K | 0.98% | 43 |
|
|
2019
Q3 | $1.3M | Sell |
17,697
-74
| -0.4% | -$5.37K | 1.13% | 38 |
|
|
2019
Q2 | $1.27M | Sell |
17,771
-126
| -0.7% | -$8.95K | 1.11% | 39 |
|
|
2019
Q1 | $1.23M | Sell |
17,897
-13
| -0.1% | -$840 | 1.12% | 42 |
|
|
2018
Q4 | $1.07M | Buy |
+17,910
| New | +$1.12M | 1.11% | 44 |
|
Other funds holding CL
Eukles Asset Management's CL Position: Q2 2026 in Review
Eukles Asset Management reduced its Colgate-Palmolive (CL) stake by 3% in Q2 2026, selling an estimated $52.3K and leaving 19,232 shares worth $1.76M. The position accounts for 0.73% of the portfolio, ranked #44.
Eukles Asset Management first reported a position in CL in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.41M in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Eukles Asset Management held 19,232 shares of Colgate-Palmolive worth $1.76M as of Q2 2026.
- Eukles Asset Management sold 598 Colgate-Palmolive shares in Q2 2026, an estimated $52.3K.
- Colgate-Palmolive made up 0.73% of Eukles Asset Management's portfolio in Q2 2026, its #44 holding.
- Eukles Asset Management first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 31 quarters since.
- Eukles Asset Management's Colgate-Palmolive position peaked at $2.41M in Q3 2024.
- 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.